Cataya Bio

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Cataya Bio - overview

Established

2021

Location

Shanghai, -, China

Primary Industry

Biotechnology

About

Established in 2021 and based in Shanghai, China, Ketaiya Biotechnology (Shanghai) Co. , Ltd. , aka Cataya Bio operates as a synthetic biology company that provides an advanced engineering biology platform and biomanufacturing. The company's team consists of executives from domestic and international synthetic biology leaders Amyris, Plum Bio and Evonik China, etc.


Lishan Zhao, the founder and CEO of the company, once served for 14 years at Amyris, a US-based synthetic biology company, as Vice President of research and development and President of China, and he has over two decades of experience in engineering biology. In January 2026, Cataya Bio raised a venture funding from Zhangjiang Haoheng Capital. The company uses synthetic biology technology and strain engineering, fermentation and extraction processes and high-throughput automation technologies, etc. to provide natural, green, sustainable and innovative raw material products, including terpenoids, amino acids and their derivatives, and oligosaccharides.


It also engages in product development in the fields of personal care, food nutrition and pharmaceutical ingredients. The company's revenue is generated by providing synthetic biology services.


Current Investors

Source Code Capital, Bits x Bites, Sherpa Healthcare Partners

Primary Industry

Biotechnology

Sub Industries

Bioinformatics, Biopharmaceuticals, Healthcare IT, Biomaterials

Website

www.cataya.com

Verticals

Artificial Intelligence, Big Data, Clean Technology

Company Stage

Series B

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.